Neuroanatomy paper riddled with errors pulled by authors

Journal-of-NeurosurgeryAuthors have retracted a paper from the Journal of Neurosurgery that contained many errors, including mislabeled figures, anatomical errors, and mismatched citations. They said that the paper’s preparation was rushed and not all authors had a chance to verify that it was accurate.

Two of the authors of the paper had previously contacted the journal to request the paper be withdrawn. Jo Ann Eliason, communications manager for the Journal of Neurosurgery, said that the withdrawal request came too late, since the paper had already been published online: Continue reading Neuroanatomy paper riddled with errors pulled by authors

Authors retract chemistry letter after new data reveal problems in reaction, structure

title

The authors of a letter describing the synthesis of ketonitrones have retracted it, after new data showed that they incorrectly reported the product structures and the reaction mechanism.

We’re not sure what exactly went wrong with the original data in the letter, “Transition-Metal-Catalyzed Ring Expansion of Diazocarbonylated Cyclic N-Hydroxylamines: A New Approach to Cyclic Ketonitrones,” published in Organic Letters. 

Here’s the reaction that the paper reported, from the abstract:

Screen Shot 2015-12-11 at 1.06.39 PM

And here’s the very short noteContinue reading Authors retract chemistry letter after new data reveal problems in reaction, structure

Eight retractions for fake reviews lead journal to suspend author nominations

home_cover (1)

An investigation has uncovered fake reviews on 21 papers submitted to the Journal of the Renin-Angiotensin Aldosterone System.

After taking a second look at accepted papers with an author-nominated reviewer, the journal discovered that the listed reviewers on the 21 papers, though real people, had never submitted a report.

Eight of the papers have been retracted by JRAAS. The rest had not yet been published, and have now been rejected, explains a commentary by the journal editors. The journal has also stopped allowing authors to nominate reviewers.

The retraction note — the same on all eight papers — explains how the authors “seriously compromised” the review process:

Continue reading Eight retractions for fake reviews lead journal to suspend author nominations

Oh no he didn’t! Misattributed Aristotle work leads to correction in highly cited cancer paper

jcoJohn Shannon may be a mere undergrad at Hillsdale College in Michigan, but he knows enough about history to be surprised that Aristotle had written an entire book about economics that Shannon had never heard of.

That curiosity led to the discovery that a highly cited paper about pricing in cancer drugs was missing a reference to a rather relevant source about a treatise by the Greek philosopher, prompting the Journal of Clinical Oncology to correct the paper. But to Shannon, a missing reference is not the only problem with the paper.

As he notes in an essay in Public Discourse, Shannon’s interest was piqued when he noticed this passage in a 2013 paper in the Journal of Clinical Oncology on the fair price — “just price,” or Justum Pretium — of cancer drugs: Continue reading Oh no he didn’t! Misattributed Aristotle work leads to correction in highly cited cancer paper

Authors retract antioxidant paper after more work reverses their conclusion

Screen Shot 2015-12-03 at 12.29.58 PM

The authors of a paper about the benefits of an antioxidant found in blueberries known as pterostilbene have retracted it after their subsequent research suggested the antioxidant might actually be harmful.

The paper presented evidence that the antioxidant might help rats after heart attack, in part by inhibiting cell death (apoptosis). But according to the retraction note, more work

found that pterostilbene might induce apoptosis in the heart and can be harmful, and we are now focusing on the phenomenon.

The rest of the retraction note for “Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-κB signaling pathway,” published in the International Journal of Clinical and Experimental Medicine, suggests that the authors would consider republishing their findings if they became more confident in the data:

Continue reading Authors retract antioxidant paper after more work reverses their conclusion

Science flags immune-boosting paper under investigation

F1.mediumScience magazine has issued an expression of concern for a paper on the discovery of a new immune-boosting protein. The paper’s findings, which received some press coverage when they came out last spring, are now under investigation by Imperial College London.

The expression of concern follows a correction noting a Western blot mix-up. Science Editor in Chief Marcia McNutt told us last month that the mistake resulted from “carelessness” on the part of the authors. But now, an investigation at Imperial College London — where Philip Ashton-Rickardt led the research — is formally looking into the findings.

That investigation is ongoing, according to the expression of concern (signed by McNutt):

Continue reading Science flags immune-boosting paper under investigation

Authors retract meningitis paper over permission — but data are in a public database

plos1A study characterizing subtypes of the bacteria that cause bacterial meningitis is being retracted after the authors didn’t have permission to publish the data, even though the data itself remain available in a public database.

The paper, in PLOS ONE, relied on a laboratory collection of patient samples. In October, the authors retracted it because they “did not have permission” from the laboratory “to publish the data in their current form.” The data — anonymized — are now available at PubMLST.

Here’s the retraction notice, published on October 16: Continue reading Authors retract meningitis paper over permission — but data are in a public database

Author added to paper after investigation at University of Helsinki

CoverIssueAn author has been added to a biochemistry paper following an investigation by the University of Helsinki.

Karen Sabatini, currently a biochemist at the University of San Diego, was erroneously left off the author list of a paper published in 2010 in Soft Matter. She apparently left Helsinki in 2010.

The circumstances may be unclear, but one thing we do know: authorship issues often take down papers entirely. Since this just warranted a correction, the mistake could have just been an oversight, rather than pointing to a larger issue.

Here’s the note for “Formation of lipid/peptide tubules by IAPP and temporin B on supported lipid membranes:”

Continue reading Author added to paper after investigation at University of Helsinki

Science retracts physics paper after magnetic field wasn’t what it seemed

F1.mediumScience has retracted an August paper on an interesting electric current researchers observed in a kind of material called a topological insulator. Well, a current the researchers — based at Stanford and MIT — thought they had observed.

A magnetic field with particular attributes reported in the paper seemed to provide evidence of the current. But the researchers soon discovered that the field might have been, in part, an artifact of the very device they used to detect it. The authors, along with a few other researchers, have published that subsequent finding on the physics preprint server, arXiv.

Here’s the retraction note:
Continue reading Science retracts physics paper after magnetic field wasn’t what it seemed

Breakfast study mischaracterized funding by cereal group

Screen Shot 2015-12-07 at 5.42.55 PM

PLOS ONE has quickly corrected an October analysis of what children in Malaysia eat for breakfast, after the study neglected to note it benefited from mistakenly noted an unrestricted research grant from cereal companies supported author salaries. The grant supported the salaries of research assistants, according to the correction note.

Per the authors’ request, the journal has noted that the study received financial support from Nestlé R&D Center in Singapore and Cereal Partners Worldwide, a collaboration between General Mills Inc. and Nestlé S.A., with the goal of selling cereal outside the US and Canada. These funders provided “salaries for research assistants” for the MyBreakfast study, on which the analysis is based, according to the note.

The paper includes authors affiliated with Nestlé and Cereal Partners Worldwide, as well as a detailed “Competing interests” section, which outlines the relationships with these companies.

The correction note explains the information that should have appeared in the funding section of the article:

Continue reading Breakfast study mischaracterized funding by cereal group